Literature DB >> 17587867

Active export proteins mediating drug resistance in staphylococci.

Karl A Hassan1, Ronald A Skurray, Melissa H Brown.   

Abstract

Drug resistance mediated by integral membrane transporters is an important mode of cellular resistance to cytotoxic agents across all classes of living organisms. Gram-positive bacteria, such as staphylococcal species, are not encapsulated by a selective outer membrane permeability barrier. Therefore, these organisms often employ integral membrane drug transport systems to maintain cellular concentrations of antimicrobials at subtoxic levels. Staphylococcal species, including the opportunistic human pathogen Staphylococcus aureus, encode a multitude of drug exporters, encompassing transporters from each of the five currently recognized families of bacterial drug resistance transporters. A number of these transporters are chromosomally encoded and allow the host cell to realize clinically significant levels of drug resistance after minor mutations to regulatory regions. Others are plasmid-encoded and can be easily passed between staphylococcal strains and species, or acquired from other Gram-positive genera. In combination, staphylococcal drug transporters potentiate resistance to a vast array of antimicrobial compounds, including macrolide, quinolone, tetracycline and streptogramin antibiotics, as well as a broad range of biocides, such as quaternary ammonium compounds, biguanidines and diamidines. An understanding of the genetic and molecular properties of drug transporters will lead to effective treatments of staphylococcal infections. Here we provide a detailed review of the active drug transporters of the staphylococci. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17587867     DOI: 10.1159/000099640

Source DB:  PubMed          Journal:  J Mol Microbiol Biotechnol        ISSN: 1464-1801


  13 in total

Review 1.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

2.  Mutations within the mepA operator affect binding of the MepR regulatory protein and its induction by MepA substrates in Staphylococcus aureus.

Authors:  Bryan D Schindler; Susan M Seo; Ivan Birukou; Richard G Brennan; Glenn W Kaatz
Journal:  J Bacteriol       Date:  2015-01-12       Impact factor: 3.490

3.  Ethidium bromide MIC screening for enhanced efflux pump gene expression or efflux activity in Staphylococcus aureus.

Authors:  Diixa Patel; Christos Kosmidis; Susan M Seo; Glenn W Kaatz
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

4.  Mode-of-action studies of the novel bisquaternary bisnaphthalimide MT02 against Staphylococcus aureus.

Authors:  Thomas M Menzel; Maximilian Tischer; Patrice François; Joachim Nickel; Jacques Schrenzel; Heike Bruhn; Annette Albrecht; Leane Lehmann; Ulrike Holzgrabe; Knut Ohlsen
Journal:  Antimicrob Agents Chemother       Date:  2010-10-11       Impact factor: 5.191

5.  Exoproteome of Staphylococcus aureus reveals putative determinants of nasal carriage.

Authors:  Gowrishankar Muthukrishnan; Gerry A Quinn; Ryan P Lamers; Carolyn Diaz; Amy L Cole; Sixue Chen; Alexander M Cole
Journal:  J Proteome Res       Date:  2011-03-07       Impact factor: 4.466

6.  Staphylococcus aureus HrtA is an ATPase required for protection against heme toxicity and prevention of a transcriptional heme stress response.

Authors:  Devin L Stauff; Danielle Bagaley; Victor J Torres; Rose Joyce; Kelsi L Anderson; Lisa Kuechenmeister; Paul M Dunman; Eric P Skaar
Journal:  J Bacteriol       Date:  2008-03-07       Impact factor: 3.490

Review 7.  Biochemistry of bacterial multidrug efflux pumps.

Authors:  Sanath Kumar; Manuel F Varela
Journal:  Int J Mol Sci       Date:  2012-04-10       Impact factor: 6.208

8.  Modulation of Bacterial Multidrug Resistance Efflux Pumps of the Major Facilitator Superfamily.

Authors:  Sanath Kumar; Mun Mun Mukherjee; Manuel F Varela
Journal:  Int J Bacteriol       Date:  2013

9.  Functional analyses reveal an important role for tyrosine residues in the staphylococcal multidrug efflux protein QacA.

Authors:  Jingqin Wu; Karl A Hassan; Ronald A Skurray; Melissa H Brown
Journal:  BMC Microbiol       Date:  2008-09-16       Impact factor: 3.605

10.  Homology modeling, molecular dynamics, and virtual screening of NorA efflux pump inhibitors of Staphylococcus aureus.

Authors:  Baki Vijaya Bhaskar; Tirumalasetty Muni Chandra Babu; Netala Vasudeva Reddy; Wudayagiri Rajendra
Journal:  Drug Des Devel Ther       Date:  2016-10-03       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.